Dr. Julie Meigs has over 20 years of intellectual property experience in life sciences after beginning her career as a research scientist.

Dr. Meigs advises clients on a wide-range of IP issues, including global patent portfolio strategy, freedom-to-operate, patent invalidity, licensing, and strategic partnerships. Dr. Meigs regularly assists venture firms and other financiers in IP due diligence for potential assets and investments, and she also guides growth stage companies in IP strategy to support successful financing rounds.

Clients value Dr. Meigs’ pragmatic leadership style and creative problem solving.  

Dr. Meigs has specific technical experience in the areas of oncology, immunology, neuroscience, infectious disease, biologics, antibodies, vaccines, diagnostics, gene editing and genomics, stem cell biology and agricultural biotechnology.

Dr. Meigs serves on the Board and the Executive Team of the North Carolina Biosciences Organization (NCBIO), the trade association for North Carolina’s life sciences industry.